JDR Vol.9 No.5 pp. 813-817
doi: 10.20965/jdr.2014.p0813


Joint Research Project on Infectious Diseases in West-African Subregion

Eiji Ido*,**, Takashi Suzuki*,**, William K. Ampofo***,
Irene Ayi***, Shoji Yamaoka*, Kwadwo A. Koram***,
and Nobuo Ohta*

*Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8510, Japan

**Ghana-Tokyo Medical and Dental University Research Collaboration Center, Legon, Ghana

***Noguchi Memorial Institute for Medical Research, College of Health Sciences, University of Ghana, Legon, Ghana

May 29, 2014
June 26, 2014
October 1, 2014
Ghana, Noguchi Memorial Institute for Medical Research, HIV, African trypanosomiasis, vector research
A research collaboration project in Ghana has joined the MEXT program supported by the Japanese government since 2008. The Noguchi Memorial Institute for Medical Research (NMIMR), the University of Ghana, and Tokyo Medical and Dental University (TMDU) are core parties in the project, and researchers from other institutions also participate temporarily. Two TMDU faculty members are sent to Ghana to manage and implement joint research projects for virology and parasitology, which cover HIV, African trypanosomes, malaria parasites, and vector insects. Along with joint research, mutual exchange activities for young researchers and students have been promoted to develop human resources in tropical infectious disease research. Subjects in our project are all public health concerns both in Ghana and West-Africa and in other parts of the world. Our joint projects have strengthened and promoted global information networks on infectious diseases and the health and welfare of the residents of Ghana and Japan.
Cite this article as:
E. Ido, T. Suzuki, W. Ampofo, I. Ayi, S. Yamaoka, K. Koram, and N. Ohta, “Joint Research Project on Infectious Diseases in West-African Subregion,” J. Disaster Res., Vol.9 No.5, pp. 813-817, 2014.
Data files:
  1. [1] L.R. Petersen, A.C. Brault, and R.S. Nasci, “West Nile virus: review of the literature,” JAMA, Vol.310, pp. 308-315, 2013.
  2. [2] National AIDS/STI Control Program, “HIV Sentinel Survey Report 2012,” Ghana Health Service, Ministry of Health, Ghana, 2013.
  3. [3] J. S. Barnor, N. Yamamoto, J. A. M. Brandful, W. Ampofo, J. H. K. Bonney, E. Bonney, J. K. Odoom, S. Aidoo, M. Alale, N. A. Ntim, Y. O. Amoah, S. B. Ofori, J. Ndzinu, I. D. Aziati, N. A. Addo, A. Nyarko, E. Ido, K. Ishikawa, and S. Yamaoka, “ Establishment of in-house quantitative real-time RT-PCR assay for HIV-1 viral load measurement and its application to evaluate efficacy of ART in Ghnanaian patients in an urban setting,” J AIDS Clin Res (in press).
  4. [4] “HIV-1 resistance mutation database,” [accessed June 26, 2014]
  5. [5] N. I. Nii-Trebi, S. Ibe, J. S. Barnor, K. Ishikawa, J. A. M. Brandful, S. B. Ofori, S. Yamaoka, W. K. Ampofo, and W. Sugiura, “HIV-1 drug-resistance surveillance among treatment -experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana,” PLOS One, Vol.8, pp. e71972, 2013.
  6. [6] World Health Organization, “World Malaria Report 2013,” [accessed June 26, 2014]
  7. [7] B. Kwansa-Bentum, I. Ayi, T. Suzuki, J. Otchere, T. Kumaga, W. K. Anyan, J. H. Osei, H. Asahi, M. F. Ofori, N. Akao, M. D.Wilson, D. A. Boakye, and N. Ohta, “Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro,” Malar J, Vol.10, pp. 187, 2011.
  8. [8] U. Eckstein-Ludwig, R. J. Webb, I. D. van Goethem, J. M. East, A. G. Lee, M. Kimura, P. M. O’Neill, P. G. Bray, S. A. Ward, and S. Krishna, “Artemisinins target the SERCA of Plasmodium falciparum.” Nature, Vol.424, pp. 957-961, 2003.
  9. [9] A. C. Uhlemann, A. Cameron, U. Eckstein-Ludwig, J. Fischbarg, P. Iserovich, F. A. Zuniga, M. Eas, A. Lee, L. Brady, R. K. Haynes, and S. Krishna, “A single amino acid residue can determine the sensitivity of SERCAs to artemisinins,” Nat Struct Mol Biol, Vol.12, pp. 628-629, 2005.
  10. [10] K. A. Koram, B. Abuaku, N. Duah, and N. Quarshie, “Comparative efficacy ofantimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana,” Acta Trop, Vol.95, pp. 194-203, 2005.
  11. [11] J. G. Kublin, J. F. Cortese, E. M. Njunju, R. A. Mukadam, J. J. Wirima, P. N. Kazembe, A. A. Djimde, B. Kouriba, T. E. Taylor, and C. V. Plowe, “Reemergence of chloroquinesensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi,” J Infect Dis, Vol.187, pp. 1870-1875, 2003.
  12. [12] T. Mita, A. Kaneko, J. K. Lum, B. Bwijo, M. Takechi, I. L. Zungu, T. Tsukahara, K. Tanabe, T. Kobayakawa, and A. Bjorkman, “Recovery of chloroquine sensitive and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuation of chloroquine use in Malawi,” Am J Trop Med Hyg, Vol.68, pp. 413-415, 2003.
  13. [13] B. Kwansa-Bentum, I. Ayi, T. Suzuki, J. Otchere, T. Kumagai, W. K. Anyan, H. Asahi, N. Akao, M. D. Wilson, D. A. Boakye, and N. Ohta, “Administrative practices of health professionals and use of artesunate-amodiaquine by community members for treating uncomplicated malaria in southern Ghana: implications for artemisinin-based combination therapy deployment,” Trop Med Int Health, Vol.16, pp. 1215-1224, 2011.
  14. [14] National HIV/AIDS/STI Control Program, “Guidelines for Antiretrovial Therapy in Ghana,” Ministry of Health/Ghana Health Service, 2010.

*This site is desgined based on HTML5 and CSS3 for modern browsers, e.g. Chrome, Firefox, Safari, Edge, Opera.

Last updated on Jun. 19, 2024